Status:
UNKNOWN
Botulinum Toxin A in the Treatment of Hemifacial Spasm
Lead Sponsor:
Tongji University
Conditions:
Hemifacial Spasm
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Hemifacial spasm patients who received botulinum toxin A injection were divided into two groups. Group A received unilateral injection while group B received bilateral injection. Patients completed fo...
Detailed Description
Hemifacial spasm patients who received botulinum toxin A injection were divided into two groups.Patients of unilateral group were injected to the affected side and the dose of botulinum toxin A was 2....
Eligibility Criteria
Inclusion
- clinical diagnosis of hemifacial spasm
- Scott grading III to IV
- hemifacial spasm duration of half or more years
- last botulinum toxin A application at least 3 months before the start of the study
Exclusion
- history of facial trauma, congenital facial asymmetry, facial nerve microsurgical decompression
- bilateral hemifacial spasm
- allergies to botulinum toxin A or to any component of the drug
- previous treatment with botulinum toxin A fewer than 3 months
- the use of drugs that could interfere with neuromuscular transmission or spasm
Key Trial Info
Start Date :
October 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03306940
Start Date
October 2 2017
End Date
August 31 2018
Last Update
October 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Tongji Hospital
Shanghai, Shanghai Municipality, China, 200065